S&P 및 Nasdaq 내재가치 문의하기

Xenon Pharmaceuticals Inc. XENE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CA • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$76.67
+29.2%

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Xenon Pharmaceuticals Inc. (XENE), 포함 28 건 매수20 건 매도. 내부자 매수 총액은 $23.98M 내부자 매도 총액은 $4.33M.

최근 활동이 있는 주요 내부자에는 Mortimer Ian, Difabio Andrea, Kenney Christopher John. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — XENE

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2026-03-13 Mortimer Ian President & CEO 정보 매도 7,308 $55.23 $403.58K 19,923
2026-03-13 Difabio Andrea Chief Legal Officer 정보 매도 1,342 $55.23 $74.11K 7,301
2026-03-13 Kenney Christopher John Chief Medical Officer 정보 매도 1,410 $55.23 $77.87K 7,069
2026-03-12 Mortimer Ian President & CEO 옵션 행사 12,500 - - 27,231
2026-03-12 Difabio Andrea Chief Legal Officer 옵션 행사 3,750 - - 8,643
2026-03-12 Kenney Christopher John Chief Medical Officer 옵션 행사 3,750 - - 8,479
2026-03-10 Mortimer Ian President & CEO 정보 매도 11,269 $60.11 $677.36K 14,731
2026-03-10 Difabio Andrea Chief Legal Officer 정보 매도 2,607 $60.11 $156.7K 4,893
2026-03-10 Kenney Christopher John Chief Medical Officer 정보 매도 2,771 $60.11 $166.56K 4,729
2026-03-09 Mortimer Ian President & CEO 옵션 행사 (매도) 20,000 - - -
2026-03-09 Difabio Andrea Chief Legal Officer 옵션 행사 (매도) 7,500 - - -
2026-03-09 Kenney Christopher John Chief Medical Officer 옵션 행사 (매도) 7,500 - - -
2026-01-09 Mortimer Ian President & CEO RSU 부여 65,000 - - 65,000
2026-01-09 Cline Darren S Chief Commercial Officer RSU 부여 20,000 - - 20,000
2026-01-09 Difabio Andrea Chief Legal Officer RSU 부여 15,000 - - 15,000
2026-01-09 Kenney Christopher John Chief Medical Officer RSU 부여 20,000 - - 20,000
2026-01-02 Mortimer Ian President & CEO 옵션 행사 (매도) 40,000 $7.49 $299.6K -
2025-12-08 Mortimer Ian President & CEO 정보 매도 2,010 $46.32 $93.1K 6,000
2025-12-05 Mortimer Ian President & CEO 정보 매도 14,375 $45.03 $647.31K 16,830
2025-11-28 Mortimer Ian President & CEO 정보 매도 97 $45.01 $4.37K 31,205
2025-10-15 Kelly Thomas Patrick Chief Financial Officer 알 수 없음 - - - -
2025-10-15 Kelly Thomas Patrick Chief Financial Officer RSU 부여 30,000 - - 30,000
2025-10-01 Mortimer Ian President, CEO & Interim CFO 옵션 행사 (매도) 25,000 $7.69 $192.25K -
2025-06-23 Cline Darren S Chief Commercial Officer 알 수 없음 - - - -
2025-06-23 Cline Darren S Chief Commercial Officer RSU 부여 185,800 $31.49 $5.85M 185,800
2025-06-05 Patou Gary Director RSU 부여 2,645 - - 2,645
2025-06-05 Machado Patrick Director RSU 부여 2,645 - - 2,645
2025-06-05 Svoronos Dawn Director RSU 부여 2,645 - - 2,645
2025-06-05 Gannon Steven Director RSU 부여 2,645 - - 2,645
2025-06-05 Gover Justin D. Director RSU 부여 2,645 - - 2,645
2025-06-05 Garofalo Elizabeth A. Director RSU 부여 2,645 - - 2,645
2025-06-05 Cannon Gillian Director RSU 부여 2,645 - - 2,645
2025-05-14 Gannon Steven Director 옵션 행사 (매도) 5,144 $12.57 $64.66K -
2025-03-12 Mortimer Ian President & CEO RSU 부여 50,000 - - 50,000
2025-03-12 Difabio Andrea Chief Legal Officer RSU 부여 15,000 - - 15,000
2025-03-12 Kenney Christopher John Chief Medical Officer RSU 부여 15,000 - - 15,000
2025-01-27 Mortimer Ian President & CEO 옵션 행사 (매도) 16,315 $17.76 $289.75K -
2025-01-24 Mortimer Ian President & CEO 옵션 행사 (매도) 22,468 $17.76 $399.03K 16,315
2025-01-23 Mortimer Ian President & CEO 정보 매도 16,217 $40.08 $649.98K 31,302
2024-12-18 Aulin Sherry Chief Financial Officer 옵션 행사 (매도) 9,334 $9.44 $88.11K -
2024-11-22 Patou Gary Director 옵션 행사 (매도) 3,086 $13.48 $41.6K -
2024-06-05 Patou Gary Director RSU 부여 15,542 $38.16 $593.08K 15,542
2024-06-05 Machado Patrick Director RSU 부여 15,542 $38.16 $593.08K 15,542
2024-06-05 Svoronos Dawn Director RSU 부여 15,542 $38.16 $593.08K 15,542
2024-06-05 Gannon Steven Director RSU 부여 15,542 $38.16 $593.08K 15,542
2024-06-05 Gover Justin D. Director RSU 부여 15,542 $38.16 $593.08K 15,542
2024-06-05 Garofalo Elizabeth A. Director RSU 부여 15,542 $38.16 $593.08K 15,542
2024-06-05 Cannon Gillian Director RSU 부여 15,542 $38.16 $593.08K 15,542
2024-03-11 Mortimer Ian President & CEO RSU 부여 250,000 $44.37 $11.09M 250,000
2024-03-11 Robin Sherrington EVP, Strategy & Innovation RSU 부여 65,000 $44.37 $2.88M 65,000
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기